Recent News for MBIO - Mustang Bio, Inc.

Date Title
Apr 7 Before You Buy Mustang Bio, Inc. (NASDAQ:MBIO), Consider Its Volatility
Mar 16 Mustang Bio EPS misses by $0.15
Mar 16 Mustang Bio Reports Full-Year 2019 Financial Results and Recent Corporate Highlights
Mar 15 3 Stocks That Should Bounce Back Once Coronavirus Fears Fade
Mar 12 The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
Feb 18 Mustang Bio Announces First Subject Treated in Phase 1/2 Trial with the Optimized CD20-targeted CAR T Cell Therapy MB-106
Jan 22 Mustang Bio to Present at the Phacilitate Leaders World & World Stem Cell Summit 2020
Dec 27 Mustang Bio, Inc. (MBIO) Upgraded to Buy: What Does It Mean for the Stock?
Dec 20 FDA OKs Daiichi antibody-drug conjugate for HER2+ breast cancer
Dec 20 Hedge Funds Are Done Buying Mustang Bio, Inc. (MBIO)
Dec 9 Mustang Bio down 18% on less effect of gene therapy on older XSCID patients
Dec 9 AR, ARQL, MBIO and DPLO among midday movers
Dec 9 Mustang Bio Announces Updated Clinical Data on MB-107 Lentiviral Gene Therapy for Patients with X-Linked Severe Combined Immunodeficiency
Dec 7 The Week Ahead In Biotech: ASH Presentations Pick Up Steam, Correvio Awaits Adcom Ruling
Dec 2 Mustang Bio to Participate in the Evercore ISI 2nd Annual HealthCONx Conference
Dec 1 The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Nov 20 Cantor sees 19% upside in J&J in premarket analyst action
Nov 12 Mustang Bio EPS beats by $0.01
Nov 12 Mustang Bio Reports Third Quarter 2019 Financial Results and Recent Corporate Highlights
Nov 6 Mustang Bio Announces MB-107 Lentiviral Gene Therapy and MB-106 CD20-Targeted CAR T Data Selected for Presentations at 61st American Society of Hematology Annual Meeting
Oct 24 Mustang Bio Announces Dosing of First Participant in Phase 1 Clinical Trial of MB-108 (Oncolytic Virus C134) to Treat Glioblastoma
Oct 10 Mustang Bio Announces City of Hope Receives $4.1 Million in Grant Awards for Recently Opened First-of-Its-Kind Clinical Trial for Patients with Recurrent Malignant Glioma
Oct 8 Have Insiders Been Buying Mustang Bio, Inc. (NASDAQ:MBIO) Shares This Year?

Back to the Main MBIO Page...